GH Research PLC (GHRS)
NASDAQ·Healthcare·Biotechnology
$21.12
+2.76%
Mkt Cap $1.45B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (11 analysts)
$36.50
Range $32.00 – $40.00
Implied Upside
+72.8%
Consensus $36.50 vs current $21.12
NASDAQ·Healthcare·Biotechnology
$21.12
+2.76%
Mkt Cap $1.45B
Buy
8
Hold
0
Sell
0
Price Target (11 analysts)
$36.50
Range $32.00 – $40.00
+72.8%
Consensus $36.50 vs current $21.12